Reply

Affiliations

¹ Unit of Gastroenterology and Rheumatology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Division of Hepatology, Department of Upper Gastrointestinal Disease, Karolinska University Hospital, Stockholm, Sweden.
² Unit of Gastroenterology and Rheumatology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Department of Medicine, Visby Hospital, Visby, Sweden.
³ Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

Comment

Annika Bergquist et al. Clin Gastroenterol Hepatol. 2020 May.

. 2020 May;18(5):1245-1246.

doi: 10.1016/j.cgh.2019.11.021. Epub 2019 Nov 12.

¹ Unit of Gastroenterology and Rheumatology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Division of Hepatology, Department of Upper Gastrointestinal Disease, Karolinska University Hospital, Stockholm, Sweden.
² Unit of Gastroenterology and Rheumatology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden; Department of Medicine, Visby Hospital, Visby, Sweden.
³ Unit of Biostatistics, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.

No abstract available

Comment on

Statin Use Is Associated With Improved Outcomes of Patients With Primary Sclerosing Cholangitis.
Stokkeland K, Höijer J, Bottai M, Söderberg-Löfdal K, Bergquist A. Stokkeland K, et al. Clin Gastroenterol Hepatol. 2019 Aug;17(9):1860-1866.e1. doi: 10.1016/j.cgh.2018.11.002. Epub 2018 Nov 15. Clin Gastroenterol Hepatol. 2019. PMID: 30448601
Associations Between Drug Exposure and Outcomes in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.
Fung BM, Ali AH, Tabibian JH. Fung BM, et al. Clin Gastroenterol Hepatol. 2020 May;18(5):1244-1245. doi: 10.1016/j.cgh.2019.09.044. Epub 2019 Oct 5. Clin Gastroenterol Hepatol. 2020. PMID: 31593771 No abstract available.